Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087009
Status:
TERMINATED
Last Update Posted:
2013-03-19
First Post:
2004-07-08
Brief Title:
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoproliferative Disorder |
| Leukemia |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| AIDS-related primary CNS lymphoma | View |
| post-transplant lymphoproliferative disorder | View |
| recurrent childhood acute lymphoblastic leukemia | View |
| recurrent childhood large cell lymphoma | View |
| recurrent childhood lymphoblastic lymphoma | View |
| recurrent childhood small noncleaved cell lymphoma | View |
| recurrentrefractory childhood Hodgkin lymphoma | View |
| AIDS-related peripheralsystemic lymphoma | View |